Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)
Clinical trial NCT01720576 · COMPLETED
Trial details
- NCT number
- NCT01720576
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.